Brief ReportsHypertrichosis of the Upper Cheek Area Associated With Travoprost Treatment of GlaucomaOrtiz-Perez, Santiago M.D.; Olver, Jane M. F.R.C.Ophth.Author Information Oculoplastic and Orbital Service, Western Eye Hospital and the Eye Department, Charing Cross, London, United Kingdom Accepted for publication November 9, 2009. None of the authors disclose any type of financial interest related to the manuscript. Address correspondence and reprint requests to Jane M. Olver, F.R.C.Ophth., Western Eye Hospital, Marylebone Road, London NW1 5QH, United Kingdom. E-mail: [email protected]. Ophthalmic Plastic & Reconstructive Surgery: September 2010 - Volume 26 - Issue 5 - p 376-377 doi: 10.1097/IOP.0b013e3181cbfbdd Buy Metrics Abstract Travoprost is a prostaglandin analog used in the treatment of open-angle glaucoma. This drug is safe and efficacious and has a low incidence of systemic and local side effects. Common local side effects are conjunctival hyperemia, iris pigmentation, and hypertrichosis of the eyelashes. The authors present a case of a patient who developed marked hypertrichosis of the cheek vellus 3 months after starting treatment with travoprost. ©2010The American Society of Opthalmic Plastic and Reconstructive Surgery, Inc.